Assessing the Occurrence of Hypertension in Patients Receiving Calcitonin Gene-Related Peptide Monoclonal Antibodies for Episodic and Chronic Migraine: A Systematic Review. [PDF]
Kakde SP +9 more
europepmc +1 more source
Persistence, switching, and healthcare use after initiating calcitonin gene-related peptide inhibitors: a real-world assessment. [PDF]
Moura CS +7 more
europepmc +1 more source
A real-world study of the efficacy and tolerability of fremanezumab in migraine patients with a median follow-up of 14 months. [PDF]
Suzuki S +8 more
europepmc +1 more source
Patient Adherence and Long-Term Tolerability of Anti-calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies in Migraine Prevention: A Systematic Review. [PDF]
Ray R +9 more
europepmc +1 more source
Normal delivery following use of galcanezumab until the first and second trimesters of pregnancy: A report of 2 cases. [PDF]
Akiyama H, Yamano Y.
europepmc +1 more source
Injection-Based Therapies for Migraine in Older Adults: A Narrative Review of OnabotulinumtoxinA, Greater Occipital Nerve Block, and Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies. [PDF]
Kang MK +10 more
europepmc +1 more source
Estimating risk of reported versus theoretical drug-drug interactions in headaches medicine: an exhaustive comparison between DrugBank and FAERS database for abortive and preventive combinations. [PDF]
Kaytser V, Hakkinen I, Dave J, Zhang P.
europepmc +1 more source
Acute Interstitial Nephritis Induced by Monoclonal Antibodies Targeting Calcitonin Gene-Related Peptide (CGRP)-Unveiling a New Association: A Case Report. [PDF]
Vargas-Brochero MJ +4 more
europepmc +1 more source
Cost-utility analysis of eptinezumab for migraine prevention in Taiwan. [PDF]
Chan CS +7 more
europepmc +1 more source
Calcitonin Gene-Related Peptide Inhibitors and Cardiovascular Events in Patients With Migraine: A Retrospective, Observational Cohort Study. [PDF]
Lusk JB +9 more
europepmc +1 more source

